BMS-962212
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-962212, covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects [Phase 1]